---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-22-002068"
form_type: "8-K"
ticker: "LNAI"
cik: "0001527728"
company_name: "Lunai Bioworks Inc."
filed_at: "2022-11-30T23:59:59+00:00"
generated_at: "2026-06-21T11:38:06.180618+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Enochian BioSciences receives second Nasdaq delisting notice over delayed 10-Q filing

## Summary
- Nasdaq notified Enochian on Nov 23, 2022, of non-compliance with Listing Rule 5250(c)(1) for failure to file Form 10-Q for period ended Sep 30, 2022.
- This follows a prior notice on Oct 17, 2022, for delayed Form 10-K (year ended Jun 30, 2022).
- Delay attributed to ongoing work by a third-party valuator on a company asset.
- Company must submit a compliance plan by Dec 16, 2022; if accepted, Nasdaq may grant until Apr 11, 2023 to file.
- Failure to regain compliance could lead to delisting from Nasdaq.

## SEC filing metadata
- accession: 0001731122-22-002068
- form_type: 8-K
- ticker: LNAI
- cik: 0001527728
- company_name: Lunai Bioworks Inc.
- filed_at: 2022-11-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527728/000173112222002068/0001731122-22-002068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527728/000173112222002068/e4267_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-22-002068
- JSON: https://secwatch.observer/filing/0001731122-22-002068.json
- Plain text: https://secwatch.observer/filing/0001731122-22-002068.txt

## Key facts
- Listing & Compliance Notices
  Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: November 23, 2022, Enochian Biosciences Inc. (the “ Company ”) received a notice (the “ Notice ”) from The Nasdaq Stock Market LLC (“ Nasdaq ”)stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “ Form 10-Q ”), the Company remains in non-compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. As previously disclosed on Form 8-K filed with the Securities and Exchange Commission on October 21, 2022, on October 1
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527728/000173112222002068/0001731122-22-002068-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.